Home
    About the Center
    Physical Activity
    Resources and Bibliography
    Aging Network
    Features
    Long Term Care Institute
    Contact Us
    Subscribe to NAN
 
Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men.
  CONTEXT: Osteoporotic fractures are common among elderly men. OBJECTIVE: To evaluate among older men the cost-effectiveness of bone densitometry followed by 5 years of oral bisphosphonate therapy to prevent fractures for those found to have osteoporosis (femoral neck T score < or =-2.5), compared with no intervention. DESIGN, SETTING, AND POPULATION: Computer Markov microsimulation model using a societal perspective and a lifetime horizon. Simulations were performed for hypothetical cohorts of white men aged 65, 70, 75, 80, or 85 years, with or without prior clinical fracture. Data sources for model parameters included the Rochester Epidemiology Project for fracture costs and population-based age-specific fracture rates; the Osteoporotic Fractures in Men (MrOS) study and published meta-analyses for the associations among prior fractures, bone density, and incident fractures; and published studies of fracture disutility. MAIN OUTCOME MEASURES: Costs per quality-adjusted life-year (QALY) gained for the densitometry and follow-up treatment strategy compared with no intervention, calculated from lifetime costs and accumulated QALYs for each strategy. RESULTS: Lifetime costs per QALY gained for the densitometry and follow-up treatment strategy were less than $50,000 for men aged 65 years or older with a prior clinical fracture and for men aged 80 years or older without a prior fracture. These results were most sensitive to oral bisphosphonate cost and fracture reduction efficacy, the strength of association between bone mineral density and fractures, fracture rates and disutility, and medication adherence. CONCLUSIONS: Bone densitometry followed by bisphosphonate therapy for those with osteoporosis may be cost-effective for men aged 65 years or older with a self-reported prior clinical fracture and for men aged 80 to 85 years with no prior fracture. This strategy may also be cost-effective for men as young as 70 years without a prior clinical fracture if oral bisphosphonate costs are less than $500 per year or if the societal willingness to pay per QALY gained is $100,000.
   
Type Journal - Bibliographic Record
Resource Type
(If applicable)
Author(s) Schousboe JT, Taylor BC, Fink HA, Kane RL, Cummings SR, Orwoll ES, Melton LJ 3rd, Bauer DC, Ensrud KE.
Book Publisher
Journal Publisher JAMA
Year 2007
Pages 629-37
Article Title
Edition 298
Contact Information
(If applicable)
Comments
(If applicable)
 
     »  Search Resource Center
       Type Keyword:

National Resource Center on Nutrition, Physical Activity & Aging
| Florida International University, OE 200, Miami, FL 33199
Phone: 305-348-1517 | Fax: 305-348-1518 | E-mail: nutrionandaging@fiu.edu


This website is supported, in part, by a grant from the Administration on Aging, Department of Health and Human
Services (DHHS). Grantees undertaking projects under government sponsorship are encouraged to express freely their
findings and conclusions. Points of view or opinions do not, therefore, reflect official DHHS policy.